Cited by 159Neuropeptides and Animal PhysiologyCardiovascular, Neuropeptides, and Oxidative Stress ResearchHeart Rate Variability and Autonomic Control

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Increases in plasma neuropeptide Y concentrations during sympathetic activation in man

Morris, M.J., Russell, A.E., Kapoor, V., Cain, M.D., Elliott, J.M., West, M.J., Wing, L.M.H., Chalmers, J.P.·1986·Journal of the Autonomic Nervous System

DOI 10.1016/0165-1838(86)90089-5

Open this paper in CoChat — free account

Abstract

Neuropeptide Y (NPY) coexists with noradrenaline in postganglionic sympathetic neurons. In order to test the hypothesis that NPY may be released along with catecholamines by activation of the sympathoadrenal system we measured plasma NPY-like immunoreactivity (NPY-LI) concentrations during cold pressor test, head up tilt and bicycle exercise in healthy volunteers. All 3 manoeuvres resulted in elevation of blood pressure, heart rate and plasma noradrenaline and adrenaline concentrations. These were accompanied by increases in plasma NPY-LI concentrations on cold pressor test and exercise, but not with head up tilt. The increases in both NPY-LI and catecholamines were greatest with exercise. These findings suggest that NPY is released at the same time as noradrenaline when sympathetic noradrenergic nerves are activated.

Integrity signals

Registry

Crossref · 10.1016/0165-1838(86)90089-5

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Some statistical methods useful in circulation research.
Wallenstein, S., Zucker, C. L., & Fleiss, J. L. (1980) · Circulation Research · doi:10.1161/01.res.47.1.1 · Cited by 3,867
Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,254
Neuropeptide Y (NPY)‐like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function
Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., Martling, C., Tatemoto, K., Mutt, V., Polak, J. M., Bloom, S. R., & Goldstein, M. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07171.x · Cited by 1,199
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat
Everitt, B. J., Hökfelt, T. G. M., Terenius, L. Y., Tatemoto, K., Mutt, V., & Goldstein, M. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90036-8 · Cited by 871
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers
Ekblad, E., Edvinsson, L. I., Wahlestedt, C., Uddman, R., Håkanson, R., & Sundler, F. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90064-8 · Cited by 741
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man
Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., & Goldstein, M. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90401-9 · Cited by 616
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine
Smedes, F., Kraak, J. C., & Poppe, H. (1982) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)80506-x · Cited by 421
Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens
Fried, G. M., Terenius, L. Y., Hökfelt, T. G. M., & Goldstein, M. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-02-00450.1985 · Cited by 261
Co-release of neuropeptide Y and catecholamines during physical exercise in man
Lundberg, J. M., Martinsson, A., Hemsén, A., Theodorsson, E., Svedenhag, J., Ekblom, B. T., & Hjemdahl, P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91837-6 · Cited by 223

Show all 22 references

Sorted by citations

Items 101–159 of 159

Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β‐adrenergic receptors
van Weperen, V. Y. H., Hoang, J. D., Jani, N. R., Khaky, A., Herring, N., Smith, C. B., & Vaseghi, M. (2024) · The Journal of Physiology · doi:10.1113/jp285945 · Cited by 14
Noradrenaline, but Not Neuropeptide Y, Is Elevated in Cerebrospinal Fluid from the Third Cerebral Ventricle following Audiovisual Stress in Gonadectomised Rams and Ewes
Turner, A. I., Rivalland, E. T. A., Clarke, I. J., Lambert, G. W., Morris, M. J., & Tilbrook, A. J. (2002) · Neuroendocrinology · doi:10.1159/000067584 · Cited by 14
“The chromatographic system consisted of a Model 480 High Precision Pump, Model Gina autosampler, Model STH 585 column oven, Chromeleon 3.03 Chromatography Data System (Dionex, Germering, Germany), Model 5100A coulometric detector equipped with a Model 5021 conditioning cell and a Model 5011 analytical cell (Environmen…”
MethodInfluential
Effects of Some Kampo Medicines on Plasma Levels of Neuropeptide Y under Venipuncture Stress
Sato, Y., Katagiri, F., Itoh, H., & Takeyama, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1757 · Cited by 14
Radioimmunoassay for plasma neuropeptide-Y in physiological and physiopathological states and response to sympathetic activation.
Miller, M. A., Sagnella, G. A., Markandu, N. D., & MacGregor, G. A. (1990) · Clinica Chimica Acta · doi:10.1016/0009-8981(90)90270-3 · Cited by 14
Attenuation of vagal action following sympathetic stimulation is modulated by prejunctional α2-adrenoceptors in the dog
Hall, G. T., & Potter, E. K. (1990) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(90)90136-7 · Cited by 14
Decreased Gastric Acid Output Following Neuropeptide Y Administration into the Lateral Cerebral Ventricle of Conscious Ratsa
Penner, S. B., Smyth, D. D., & Glavin, G. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16157.x · Cited by 14
Neuropeptide Y – Its role in human performance and extreme environments
Kienast, C., Gunga, H., & Steinach, M. (2019) · REACH · doi:10.1016/j.reach.2019.100032 · Cited by 12
The Effects of α-Trinositol on Haemodynamic Variables and Neuropeptide Y Levels in a Pilot Study of Hypertensives and Healthy Volunteers
Lind, H., Brudin, L. H., Castenfors, J., Hedner, T., Lindholm, L. H., & Edvinsson, L. I. (1994) · Blood Pressure · doi:10.3109/08037059409102264 · Cited by 12
Plasma and Tissue Levels of Neuropeptide Y in Experimental Septic Shock: Relation to Hemodynamics, Inflammation, Oxidative Stress, and Hemofiltration
Kuncová, J., Sýkora, R., Chvojka, J., Švíglerová, J., Štengl, M., Kroužecký, A., Nalos, L., & Matějovič, M. (2011) · Artificial Organs · doi:10.1111/j.1525-1594.2010.01154.x · Cited by 10
“Study limitations Although NPY concentration in the plasma has been proposed as a useful indicator of sympathetic nervous system activity under stress conditions (50), relations between the sympathetic activity indices and NPY and norepinephrine systemic levels under conditions of severe sepsis or septic shock have no…”
Background
Radioimmunoassay of plasma neuropeptide Y using HPLC for separation of related peptides and fragments
Salsen, L., Andersen, H. B., Bratholm, P. S., & Christensen, N. J. (1994) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519409088426 · Cited by 10
Vascular and brain neuropeptide Y in banded and spontaneously hypertensive rats
Morris, M. J., Tortelli, C. F., Hart, D. P., & Delbridge, L. M. D. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.006 · Cited by 10
Involvement of neuropeptide Y in glucose sensing in the dorsal hypothalamus of streptozotocin diabetic rats – in vitro and in vivo studies of transmitter release
Gozali, M., Pavia, J., & Morris, M. J. (2002) · Diabetologia · doi:10.1007/s00125-002-0890-x · Cited by 10
“Each sample was centrifuged and the supernatant was stored at –20°C for subsequent radioimmunoassay of NPY-like immunoreactivity (NPYLI) using an antibody raised in the rabbit and [125I]-NPY labelled with Bolton and Hunter reagent (2000 Ci/mmol, Amersham Australia) as described previously [27].”
Method
Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat
Pham, T. M., de Champlain, J., & Couture, R. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168770 · Cited by 10
Effects Of Blockade Of α‐ and β‐Adrenoceptors And Neuropeptide Y1 Receptors, As Well As Brachial Plexus Blockade, On Endothelium‐Dependent Vasodilation In The Human Forearm
Johansson, K., Eriksson, M., Wahlqvist, I., Mühlen, B. V. Z., & Lind, L. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03695.x · Cited by 9
“Neuropeptide Y (NPY) is another vasoactive agent that is coreleased with NA when the SNS is activated.(9) The vasopressor activity of NPY is associated with the activation of the NPY Y1 receptor.”
Background
Interactions of Neurotransmitters and Endothelial Cells in Determining Vascular Tone
Shepherd, J. T. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1895-2_1 · Cited by 9
Human sympathetic neuronal discharge and recruitment patterns regulate neuropeptide Y bioavailability
Klassen, S. A., Limberg, J. K., Harvey, R. E., Wiggins, C. C., Spafford, J. E., Iannarelli, N. J., Senefeld, J. W., Nicholson, W. T., Curry, T. B., Joyner, M. J., et al. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00639.2024 · Cited by 8
Effect of oral administration of nifedipine on neuropeptide Y‐ and noradrenaline‐induced vasoconstriction in the human forearm
Pernow, J., Lundberg, J. M., & Kaijser, L. (1989) · Clinical Physiology · doi:10.1111/j.1475-097x.1989.tb00957.x · Cited by 7
Neuropeptide Y in human hand veins: Pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivo*
Peduzzi, P., Simper, D., Linder, L., Strobel, W. M., & Haefeli, W. E. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90024-1 · Cited by 8
In vitro studies of endogenous noradrenaline and NPY overflow from the rat hypothalamus during maturation and ageing
Hastings, J. A., McClure-Sharp, J. M., & Morris, M. J. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005160 · Cited by 8
Neuropeptide Y-like immunoreactivity of plasma during hypoglycaemia in man
Russell, A. E., Cain, M. D., Kapoor, V., Morris, M. J., & Chalmers, J. P. (1989) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(89)90111-2 · Cited by 8
The influence of physical exercise on alterations in concentrations of neuropeptide Y, leptin and other selected hormonal and metabolic parameters in sportspeople
Zajadacz, B., Skarpańska-Stejnborn, A., Brzenczek‐Owczarzak, W., Juszkiewicz, A., Naczk, M., & Adach, Z. (2009) · Biology of Sport · doi:10.5604/20831862.901136 · Cited by 8
Neuropeptide Y analog with selective antagonism of effects mediated by postjunctional Y1 receptors
Tseng, A., Inglis, A. S., SELBIE, L. A., Moriarty, M., & Potter, E. K. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90783-8 · Cited by 7
Neuropeptide Y and Cardiovascular Function
Morris, M. J. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18764-3_11 · Cited by 7
Environmental Stress and Immunity: Possible Implications for IgE-Mediated Allergy
Parker, C. W. (1991) · Perspectives in biology and medicine · doi:10.1353/pbm.1991.0002 · Cited by 7
Sympathetic Neural Control in Humans with Anxiety‐Related Disorders
Bigalke, J. A., & Carter, J. R. (2021) · Comprehensive physiology · doi:10.1002/j.2040-4603.2022.tb00206.x · Cited by 6
“Human studies have indicated that ATP and NPY are both responsive to sympathetic activation and carry out modulatory effects on the peripheral vasculature (51, 229, 230, 257, 310).”
Neuropeptide Y, an orexigenic hormone, regulates phagocytic activity of lizard splenic phagocytes
Kumar, S., & Rai, U. (2011) · Peptides · doi:10.1016/j.peptides.2011.04.012 · Cited by 6
Hypothetical hormonal mechanism by which potassium-rich diets benefit patients with rheumatoid arthritis
Rastmanesh, R. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.05.035 · Cited by 6
“activity [64].”
α2-Adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogs
Briand, R., Yamaguchi, N., Gagné, J., Nadeau, R. A., & de Champlain, J. (1990) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(90)90134-5 · Cited by 6
Neuropeptide Tyrosine in the Cardiovascular Systema
Wharton, J., & Polak, J. M. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb48927.x · Cited by 6
Link between emotional and external eating behaviors, peripheral neuropeptide Y, and β-hydroxybutyrate in participants with obesity on 12-week ketogenic diet
Černelič-Bizjak, M., Kenig, S., Petelin, A., Pražnikar, Z. J., & Mohorko, N. (2023) · Nutrition and Health · doi:10.1177/02601060231154464 · Cited by 5
“…was even proposed that pNPY might be a biomarker of obesity (Zhang et al., 2014). pNPY is also the product of SAS, where it is co-transmitted with NA (Ekblad et al., 1984; Morris et al., 1986) and is strongly implicated in the stress-related visceral fat mass expansion (Hirsch and Zukowska, 2012).”
Neural and Reflex Control of the Circulation
Levy, M. N. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-275820-1.50006-6 · Cited by 5
Lack of Relationship Between Sympathetic Nervous System Activity, Measured by Two Circulating Markers, and Blood Pressure in Diabetic and Nondiabetic Subjects
Carstensen, E., Sampson, M., Savage, M. W., Ware, M., Williams, G., & Yudkin, J. S. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00079-2 · Cited by 5
Neurogenic Atherosclerosis Mediated by Neuropeptide Y
Sobey, C. G. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000078582.90403.e6 · Cited by 5
Neuropeptide Y and Sympathetic Transmission
Haass, M., & Schömig, A. (1989) · Springer eBooks · doi:10.1007/978-3-642-74317-7_2 · Cited by 5
Greater lactate accumulation does not alter peripheral concentrations of key appetite-regulating neuropeptides
McCarthy, S. F., Bornath, D. P. D., Tucker, J. A. L., Cohen, T. R., Medeiros, P. J., & Hazell, T. J. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00559.2024 · Cited by 4
Functional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans
Wakeham, D. J., Hissen, S. L., MacNamara, J. P., Davis, S. L., Fadel, P. J., Levine, B. D., & Hearon, C. M. (2025) · The Journal of Physiology · doi:10.1113/jp288412 · Cited by 4
“NPY is known to increase with exercise in humans (Eugster et al., 2022; Lundberg et al., 1985; Morris et al., 1986) and is therefore likely to contribute to the regulation of blood flow in contracting skeletal muscle.”
Indices of sympathetic activity and the paradox of chromogranin A
Lambert, G. W., & Grassi, G. M. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833857e3 · Cited by 4
Role of Sympathovagal Imbalance in Gestational Hypertension: A Mini-Review
Karthiga, K., Pal, G. K., Velkumary, S., Papa, D., & Nanda, N. (2019) · International Journal of Clinical and Experimental Physiology · doi:10.5530/ijcep.2019.6.4.30 · Cited by 3
“, neuropeptide Y.[65] All biomarkers of sympathetic activity has the limitation of being affected by numerous confounding factors that can make interpretation difficult.”
Background
Plasma Neuropeptide Y During Dynamic Exercise in Patients with Essential Hypertension
Pruszczyk, P., & Chlebus, M. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509033634 · Cited by 4
Ventricular Fibrillation Induced by Ischemia-Reperfusion Is Not Prevented by the NPY Y2 Receptor Antagonist BIIE0246
Ilebekk, A., Eriksen, M., Sevre, K., Aspelin, T., Björkman, J., Lyberg, T., & Nordlander, M. (2006) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248406292709 · Cited by 3
Differential regulation of neuropeptide Y and catecholamine production in superior cervical ganglion cultures
MAREK, K. L., & Mains, R. E. (1990) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(90)90008-r · Cited by 3
PLASMA NEUROPEPTIDE Y AND ATRIAL NATRIURETIC PEPTIDE CONCENTRATIONS IN MAN
Russell, A. E., Aylward, P. E., Smith, S. A., Cain, M. D., McRitchie, R. J., & Chalmers, J. P. (1988) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1988.tb01041.x · Cited by 2
Common Features of Neuropeptide Y and Noradrenaline Release in Guinea Pig Heart
Haass, M., Richardt, G., Lang, R. E., & Schömig, A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb48980.x · Cited by 2
Modulatory Role of Nitric Oxide on the Vasomotor Actions of NPY in Porcine Cerebral Arteries
Delgado, G., Morse, C. J., Barlage, B., Laughlin, M. H., Emter, C. A., Boerman, E. M., Padilla, J., Tomczak, C. R., & Olver, T. D. (2025) · Microcirculation · doi:10.1111/micc.70016 · Cited by 1
Chapter 1 Neuroendocrine Immune Control Mechanisms and their Influence on Autoimmune Disease
Capellino, S., & Straub, R. H. (2008) · Technical report · doi:10.1016/s1571-5078(07)00201-2 · Cited by 1
Comparison of the effects of pantethine and fursultiamine on plasma levels of adrenocorticotropic hormone and neuropeptide Y under continual stress exposure
Itoh, H., Suzuki, Y., Yamamura, R., Tatsuta, R., Sato, Y., & Takeyama, M. (2012) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2012.03.002 · Cited by 1
Mirtazapine suppresses the increases in plasma levels of adrenocorticotropic hormone and neuropeptide Y under continual stress exposure
Suzuki, Y., Itoh, H., Abe, T., Tatsuta, R., Sato, Y., & Takeyama, M. (2012) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2011.12.001 · Cited by 1
Stress and food intake: what's the deal with your meal.
Tryon, M. S., & Laugero, K. D. (2011) · CABI Reviews · doi:10.1079/pavsnnr20116034 · Cited by 2
Pheochromocytoma Associated with Nocturnal Hypertension.
Ishiyama, Y., Teruhiko, O. H. G. I., Kita, T., Sasaki, A., Kitamura, K., Kida, O., Kawasaki, T., & Eto, T. (1993) · Internal Medicine · doi:10.2169/internalmedicine.32.781 · Cited by 1
Inhibition of arterial baroreceptor and chemoreceptor reflex responses by neuropeptide Y in anaesthetised dogs
Moriarty, M., Potter, E. K., & McCloskey, D. I. (1992) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(92)90010-e · Cited by 1
Sensory Stimulation (Electro-Acupuncture) and Physical Exercise, Effects on Blood Pressure, and Nociception
Bucinskaite, V., Crumpton, K., Theodorsson, E., & Lundeberg, T. (1998) · International Journal of Neuroscience · doi:10.3109/00207459808986449 · Cited by 1
Actions of appetite regulating peptides on supraoptic nucleus (SON) oxytocin neurones
Velmurugan, S. (2009) · ERA · Cited by 1
Peripartum changes in the orexigenic CNS peptide neuropeptide-Y in gestational diabetics
Anchan, R. M., Lindsey, J. L., Newton, E. R., Thyfault, J. P., & DeVente, J. (2013) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-2-23
“NPY is expressed at very high levels by hypothalamic neurons in the arcuate nucleus as well as in various sympathetic neurons where it functions as a neurotransmitter to mediate appetite, body fat composition, and insulin resistance through its own receptors Y1-5, inhibition of anorexigenic signals, and sympathetic ac…”
Background
This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome.
Antoni, M. H., Zeng, X. R., Barnes, Z. M., Harvey, J. M., & Hurwitz, B. E. (2010)
Wpływ neuropeptydu Y na regulację czynności układu krążenia
Swoboda, R., & Jochem, J. (2010) · Annales Academiae Medicae Silesiensis
Transgenic mice overexpressing neuropeptide Y: An experimental model of metabolic and cardiovascular diseases
Ruohonen, S. T. (2009) · UTUPub (University of Turku)
Effects of Simulated Pathophysiology on the Performance of a Decision Support Medical Monitoring System for Early Detection of Hemodynamic Decompensation in Humans
Joyner, M. J. (2014)
Full Conference Proceedings
Cohen, E. (2014) · Informing Science and IT Education Conference · doi:10.28945/2035
Neuropeptides in Human Cardiovascular Regulation
Pernow, J. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-232350-8.50020-0

Authors: Morris, M. J., Russell, A. E., Kapoor, V., Cain, M. D., Elliott, J. M., West, M. J., Wing, L. M. H., & Chalmers, J. P.
Affiliations: Flinders Medical Centre (AU)
ORCID: Morris, M.J.
Elliott, J.M.
West, M.J.
Chalmers, J.P.
Venue: Journal of the Autonomic Nervous System
Publisher: Elsevier BV
Published: 1986-10
Volume: 17
Issue: 2
Pages: 143-149
ISSN: 0165-1838 (ISSN-L)
DOI: 10.1016/0165-1838(86)90089-5
OpenAlex: W2001937802
Cited by: 159
References: 22
Citations by year: 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2017: 1 · 2014: 4 · 2013: 2 · 2012: 3
FWCI: 2.24
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the Autonomic Nervous System (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords: neuropeptide Y, sympathetic activation, sympathoadrenal system, norepinephrine, catecholamines, epinephrine, cold pressor test, head-up tilt, physical activity, blood pressure, heart rate
MeSH terms: Adult, Blood Pressure, Chromatography, High Pressure Liquid, Cold Temperature, Epinephrine, Exercise Test, Female, Heart Rate, Humans, Immersion, Male, Middle Aged, Neuropeptide Y, Norepinephrine, Posture, Radioimmunoassay, Sympathetic Nervous System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increases in plasma neuropeptide Y concentrations during sympathetic activation in man

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks